Blood Glucose Monitoring Devices Market Players:
- Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd
- Ascensia Diabetes Care Holdings AG
- Dexcom, Inc.
- NIPRO CORPORATION
- Prodigy Diabetes Care, LLC
- ACON Laboratories, Inc.
- Insulet Corporation
- Ypsomed AG
- Terumo Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of blood glucose monitoring devices is assessed at USD 21.16 billion.
The global blood glucose monitoring devices market size was valued at around USD 19.71 billion in 2025 and is projected to grow at a CAGR of more than 8.2%, reaching USD 43.35 billion revenue by 2035.
North America blood glucose monitoring devices market is predicted to capture 38.8% share by 2035, driven by rising diabetes cases and increasing adoption of advanced monitoring devices.
Key players in the market include Abbott Laboratories, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., NIPRO CORPORATION, Prodigy Diabetes Care, LLC, ACON Laboratories, Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation.
